four
human
coronavirus
hcov
distribut
worldwid
associ
rang
respiratori
symptom
discoveri
sever
acut
respiratori
syndrom
sar
cov
middl
east
respiratori
syndrom
mer
cov
show
hcov
pose
signific
threat
human
health
work
aim
develop
sensit
method
mcovm
identifi
known
hcov
accur
also
abil
provid
clue
emerg
hcov
method
perform
use
massarray
matrixassist
laser
desorptionion
timeofflight
mass
spectrometri
malditof
ms
system
develop
analysi
detect
six
hcov
panel
anoth
analysi
detect
alphacoronaviru
betacoronaviru
panel
b
test
primer
probe
mcovm
method
effect
crossreact
observ
common
respiratori
virus
confirm
use
mcovm
method
screen
pharyng
andor
anal
swab
sampl
collect
batsrod
nasal
throat
swab
human
patient
result
show
good
concord
result
metagenom
analysi
pcrsequenc
valid
test
show
mcovm
method
detect
potenti
pathogen
cov
alphacoronaviru
betacoronaviru
provid
convincingli
phylogenet
evid
unknown
cov
mcovm
method
sensit
assay
rel
simpl
carri
propos
method
use
complement
next
gener
sequenc
technolog
largescal
screen
studi
coronavirus
cov
larg
envelop
positivesens
rna
virus
caus
respiratori
enter
hepat
neurolog
diseas
rang
anim
includ
human
lai
et
al
accord
latest
criteria
intern
committe
taxonomi
virus
cov
classifi
four
genera
includ
alphacoronaviru
betacoronaviru
deltacoronaviru
gammacoronaviru
six
human
coronavirus
hcov
sever
acut
respiratori
syndrom
coronaviru
sarscov
middl
east
respiratori
syndrom
coronaviru
merscov
belong
alphacoronaviru
betacoronaviru
usual
associ
rel
mild
respiratori
symptom
detect
rate
rang
respiratori
specimen
accord
differ
studi
gaunt
et
al
gadsbi
et
al
trombetta
et
al
sar
emerg
china
rapidli
spread
respiratori
ill
fatal
rate
close
sarscov
found
lineag
b
betacoronaviru
confirm
etiolog
agent
sar
drosten
et
al
ksiazek
et
al
lee
et
al
peiri
et
al
merscov
detect
human
lineag
c
betacoronaviru
differ
hcov
viru
caus
sever
acut
respiratori
infect
sari
patient
fatal
rate
close
led
new
awar
medic
import
hcov
zaki
et
al
de
groot
et
al
june
laboratori
confirm
case
merscov
infect
death
countri
http
wwwwhointemergenciesmerscoven
emerg
sarscov
merscov
suggest
highli
pathogen
hcov
remain
key
threat
human
health
sever
communic
sar
sari
rapid
sensit
diagnost
method
essenti
time
implement
effect
infect
control
measur
prevent
transmiss
million
pilgrim
across
globe
perform
hajj
annual
increas
risk
global
transmiss
merscov
sharifyakan
kanj
larg
number
tourist
travel
middl
east
also
increas
risk
transmit
merscov
area
thu
import
develop
highthroughput
sensit
method
detect
hcov
especi
merscov
isol
viru
clinic
specimen
cell
cultur
regard
gold
standard
laboratori
diagnosi
respiratori
viru
infect
howev
hcov
attempt
isol
viru
long
turnaround
time
hcov
difficult
cultur
make
detect
result
lack
timeli
compar
cell
cultur
molecular
test
revers
transcript
polymeras
chain
reaction
rtpcr
nest
rtpcr
quantit
realtim
rtpcr
assay
qpcr
rapid
superior
sensit
van
der
hoek
et
al
bellaupujol
et
al
vijgen
et
al
vabret
et
al
gaunt
et
al
date
molecular
test
accept
worldwid
import
method
diagnos
hcov
infect
howev
current
molecular
method
target
singl
hcov
gene
limit
applic
mutat
occur
hcov
genom
thu
fals
neg
result
return
target
one
gene
view
lesson
learn
mer
sar
outbreak
cov
abil
interspeci
transmiss
may
emerg
novel
pathogen
chan
et
al
ge
et
al
therefor
ideal
diagnosi
method
identifi
known
hcov
accur
also
abil
provid
clue
emerg
hcov
howev
current
molecular
assay
target
hcov
may
caus
fals
neg
result
face
novel
hcov
infect
studi
design
evalu
multiplex
cov
test
mcovm
detect
known
hcov
potenti
discov
new
hcov
nt
clearli
describ
yet
new
method
consist
two
panel
panel
design
cover
six
known
hcov
panel
b
design
cover
known
cov
alphacoronaviru
betacoronaviru
develop
expand
detect
spectrum
method
base
massarray
matrixassist
laser
desorpt
ionizationtim
flight
malditof
mass
spectrometri
ms
system
agena
bioscienc
inc
san
diego
ca
usa
use
pathogen
detect
success
includ
common
respiratori
virus
human
papillomaviru
human
polyomaviru
human
enteroviru
staphylococcu
aureu
yang
et
al
soderlundstrand
et
al
basu
et
al
syrmi
et
al
li
et
al
li
et
al
peng
et
al
peng
et
al
b
peng
et
al
zhang
et
al
likewis
mcovm
method
use
multiplex
pcr
conjug
malditof
ms
technolog
achiev
highthroughput
cov
detect
method
divid
three
stage
multiplex
pcr
primer
extens
malditof
ms
identif
briefli
target
amplifi
via
multiplex
pcr
follow
incub
shrimp
alkalin
phosphatas
sap
dephosphoryl
unincorpor
dntp
primer
extens
stage
sitespecif
short
oligonucleotid
primer
bind
respect
amplicon
extend
singl
base
substrat
use
reaction
ddntp
final
malditof
ms
use
measur
mass
extend
primer
accur
thu
receiv
posit
neg
result
everi
target
oeth
et
al
repres
hcov
strain
use
design
mcovm
method
shown
supplementari
tabl
cov
genom
sequenc
use
primer
extens
probe
design
obtain
genbank
http
wwwncbinlmnihgovgenbank
specif
primer
extens
probe
supplementari
tabl
use
studi
design
use
assay
design
agena
bioscienc
inc
studi
develop
analysi
detect
six
hcov
panel
anoth
analysi
detect
alphacoronaviru
betacoronaviru
panel
b
panel
includ
specif
primer
extens
probe
target
rnadepend
rna
polymeras
rdrp
nucleocapsid
n
gene
six
hcov
ribonucleas
p
intern
control
addit
sarscov
merscov
also
design
primer
extens
probe
target
gene
region
upstream
e
gene
upe
panel
b
includ
specif
primer
extens
probe
target
rdrp
gene
cov
alphacoronaviru
betacoronaviru
primari
pcr
iplex
reaction
mcovm
method
perform
use
proflex
pcr
system
appli
biosystem
usa
accord
modifi
protocol
previous
describ
peng
et
al
pcr
mix
contain
templat
final
concentr
nucleotid
mix
datp
dgtp
dctp
dutp
nm
primer
mix
u
dna
polymeras
enzym
mm
mgcl
u
uracildna
glycosylas
reaction
condit
primari
pcr
c
min
denatur
step
min
c
follow
cycl
c
c
c
min
final
extens
step
c
min
steril
water
use
neg
control
sap
use
dephosphoryl
primari
pcr
mix
follow
c
min
c
min
sap
treatment
iplex
reaction
singlebas
extens
reaction
mix
includ
termin
mix
extens
probe
mix
iplex
pro
buffer
thermosequenas
enzym
ad
iplex
reaction
desalt
sampl
dispens
perform
accord
standard
procedur
agena
bioscienc
inc
data
acquir
analyz
use
typer
softwar
agena
bioscienc
inc
use
plasmid
contain
nearli
fulllength
sequenc
target
gene
hcov
determin
analyt
sensit
mcovm
method
plasmid
dilut
seri
concentr
copi
per
reaction
test
plasmid
concentr
perform
triplic
sampl
use
studi
obtain
collect
institut
isol
total
rna
dna
sampl
use
qiagen
dnarna
isol
kit
qiagen
germani
accord
manufactur
instruct
evalu
specif
mcovm
method
use
sampl
previous
confirm
posit
hcov
ren
et
al
zhang
et
al
two
bat
sarslik
coronaviru
isol
bat
panel
common
respiratori
virus
ren
et
al
n
also
use
determin
specif
mcovm
method
tabl
potenti
biohazard
materi
handl
requir
level
biosafeti
laboratori
experi
collect
sampl
sampl
hand
oper
train
protect
etc
carri
accord
approv
biosafeti
standard
guidelin
set
institut
pathogen
biolog
chines
academi
medic
scienc
peke
union
medic
colleg
test
mcovm
method
involv
pharyng
andor
anal
swab
sampl
collect
bat
n
rodent
n
part
bat
rodent
virom
project
alphacoronaviru
betacoronaviru
sampl
bat
rodent
also
screen
use
rtpcr
rdrp
gene
cov
comparison
next
gener
sequenc
technolog
ngst
result
bat
sampl
anoth
studi
also
includ
wu
et
al
screen
nasal
throat
swab
obtain
patient
hcov
use
mcovm
method
result
compar
method
describ
follow
four
common
hcov
also
screen
use
pcr
nest
pcr
assay
follow
sequenc
analysi
accord
previous
report
method
van
der
hoek
et
al
bellaupujol
et
al
vabret
et
al
screen
sarscov
sarslik
cov
use
method
describ
world
health
organ
http
wwwwhointcsrsarsprimersen
screen
merscov
sampl
use
qpcr
assay
develop
corman
et
al
b
test
differ
detect
rate
two
differ
method
use
test
p
consid
statist
signific
primer
probe
use
mcovm
method
evalu
use
blastn
search
nonredund
nucleotid
databas
nation
center
biotechnolog
inform
panel
b
test
carri
simultan
separ
accord
actual
need
sensit
test
show
panel
mcovm
method
accur
detect
six
target
hcov
limit
detect
mcovm
method
copi
per
assay
panel
tabl
exampl
merscov
panel
abl
detect
copi
n
upe
copi
rdrp
figur
expect
neg
control
yield
posit
result
mcovm
method
use
hcovposit
sampl
evalu
common
hcov
assay
merscov
assay
two
sarslik
cov
isol
evalu
sarscov
assay
use
pool
bat
pharyng
anal
swab
sampl
valid
perform
mcovm
sampl
collect
provinc
part
bat
virom
project
wu
et
al
among
pool
test
posit
method
seventeen
pool
identifi
panel
assay
sarscov
show
good
concord
result
sarslik
cov
mean
metagenom
analysi
wu
et
al
tabl
six
pool
also
confirm
lineageb
betacov
panel
b
assay
found
sampl
obtain
two
posit
result
panel
assay
obviou
multipl
target
use
panel
avoid
fals
neg
result
five
pool
confirm
lineageb
betacov
pcrsequenc
method
seem
mcovm
method
sensit
pcr
method
p
test
interestingli
pool
obtain
sarsupeposit
result
detect
panel
b
assay
pcr
method
target
cov
rdrp
gene
result
consist
earlier
research
demonstr
upe
assay
sensit
test
coronaviru
detect
corman
et
al
chan
et
al
remain
three
pool
identifi
alphacoronaviru
panel
b
assay
ascertain
pcrsequenc
method
anoth
rodent
pharyng
anal
swab
pool
collect
eight
provinc
across
china
also
screen
novel
method
total
pool
classifi
lineagea
betacoronaviru
panel
b
assay
pcrsequenc
verifi
two
tabl
use
mcovm
method
analyz
nasal
throat
swab
mcovm
method
detect
hcov
sampl
result
ident
use
combin
pcr
sequenc
techniqu
detect
specimen
respect
sarscov
merscov
detect
sampl
emerg
sarscov
merscov
test
abil
design
new
diagnost
method
rapid
detect
lesson
sar
show
adequ
prepar
first
pandem
twentyfirst
centuri
de
wit
et
al
took
sever
month
confirm
caus
agent
sarscov
fortun
advanc
molecular
technolog
especi
ngst
allow
us
time
accur
identifi
merscov
import
virus
rapidli
accur
identifi
order
assist
commenc
appropri
treatment
regimen
patient
emerg
merscov
highlight
impact
hcov
human
health
chan
et
al
sever
studi
shown
hcov
like
origin
wild
anim
host
bat
calish
et
al
wang
et
al
woo
et
al
shi
colleagu
found
sarslik
cov
chines
horsesho
bat
suggest
bat
natur
reservoir
sarscov
palm
civet
incident
host
li
et
al
ge
et
al
huynh
et
al
found
might
share
common
ancestri
alphacoronavirus
north
american
tricolor
bat
huynh
et
al
sever
group
shown
merscov
also
like
origin
bat
annan
et
al
ithet
et
al
base
neutral
serum
antibodi
test
reusken
et
al
show
merscov
relat
viru
infect
camel
reusken
et
al
multidisciplinari
team
virologist
isol
merscov
dromedari
camel
haagman
et
al
alagaili
et
al
also
show
merscov
circul
camel
nearli
year
howev
evid
merscov
figur
analysi
dilut
seri
merscov
plasmid
use
mcovm
method
copyreact
b
copiesreact
c
copiesreact
copiesreact
e
copiesreact
mass
spectrometri
mass
spectra
dot
line
left
dot
line
right
repres
unextend
primer
extend
primer
assay
respect
frontier
microbiolog
wwwfrontiersinorg
infect
domest
goat
sheep
alagaili
et
al
identif
sarscov
merscov
indic
viral
crossspeci
transmiss
real
threat
human
health
chan
et
al
de
wit
et
al
recent
menacheri
et
al
suggest
cluster
sarslik
cov
circul
bat
popul
show
potenti
human
emerg
menacheri
et
al
possibl
addit
cov
circul
wild
could
infect
human
confirm
largescal
studi
screen
sampl
variou
wild
anim
world
need
conduct
howev
possibl
fals
neg
result
would
seen
use
convent
detect
method
target
one
gene
genet
divers
hcov
clinic
laboratori
shown
qpcr
assay
sensit
detect
method
also
quantit
vijgen
et
al
gaunt
et
al
qpcrbase
method
target
singl
gene
viru
gaunt
et
al
perform
largescal
screen
four
common
hcov
use
qpcr
assay
therebi
significantli
improv
hcov
diagnosi
gaunt
et
al
shown
qpcr
assay
play
import
role
detect
identif
merscov
multipl
method
target
differ
gene
merscov
develop
use
detect
merscov
corman
et
al
success
develop
sever
qpcr
assay
target
upe
corman
et
al
b
anoth
studi
lu
et
al
develop
multiplex
qpcr
assay
target
n
gene
upe
region
lu
et
al
howev
avail
fluoresc
dye
limit
multiplex
capac
qpcr
assay
mcovm
method
develop
target
two
four
gene
make
power
method
screen
sampl
human
anim
result
also
show
multipl
target
use
panel
avoid
fals
neg
result
valid
test
show
method
target
potenti
pathogen
cov
alphacoronaviru
betacoronaviru
provid
convincingli
phylogenet
evid
unknown
cov
thu
method
effect
way
expand
cov
detect
spectrum
ngst
abl
gener
larg
amount
data
random
sequenc
wide
use
pathogen
detect
haagman
et
al
includ
deciph
bat
virom
group
wu
et
al
cov
larg
rna
genom
high
frequenc
mutat
recombin
convent
molecular
diagnosi
requir
prior
knowledg
target
wherea
ngst
provid
unbias
result
point
ngst
sensit
pcr
especi
screen
rna
viru
high
frequenc
variat
howev
high
cost
long
turnaround
time
sophist
bioinformat
analysi
requir
limit
number
sampl
sequenc
mcovm
method
use
complement
ngst
method
largescal
screen
studi
one
hand
screen
larg
number
sampl
use
mcovm
method
select
posit
sampl
suspici
posit
sampl
analyz
use
ngst
method
hand
new
assay
incorpor
mcovm
method
memish
et
al
largest
known
outbreak
mer
outsid
arabian
peninsula
occur
republ
korea
outbreak
associ
singl
person
return
middl
east
involv
hospit
patient
korea
center
diseas
control
prevent
encourag
member
state
continu
surveil
acut
respiratori
infect
particular
sari
http
unit
kingdom
establish
surveil
system
screen
peopl
middl
east
merscov
thoma
et
al
mcovm
method
suitabl
choic
type
screen
possibl
one
technician
analyz
two
plate
within
h
found
limit
mcovm
method
like
mention
previou
report
peng
et
al
hcov
load
low
sampl
mcovm
method
may
fail
detect
volum
sampl
use
use
larger
primari
pcr
volum
sever
primari
pcr
reaction
sampl
point
method
base
known
cov
sequenc
far
possibl
cover
known
cov
difficult
detect
new
hcov
use
mcovm
method
howev
provid
clue
new
hcov
detect
compar
current
method
studi
carri
accord
recommend
nation
ethic
regul
approv
ethic
committe
institut
pathogen
biolog
written
inform
consent
subject
subject
gave
written
inform
consent
accord
declar
helsinki
protocol
approv
ethic
committe
institut
pathogen
biolog
jp
conceiv
experi
analyz
result
wrote
manuscript
lx
cz
conduct
experi
analyz
result
zw
collect
specimen
author
review
manuscript
